Living evidence synthesis 25.1: Effectiveness of trivalent and quadrivalent influenza vaccines in preventing infection, hospitalization, and severe outcomes in the 2023–2024 season onwards

Wu, N; Bain, T; Bhuiya, AR; Phelps, A; Dass, R; Sivanesanathan, T; Wilson, MG

Living evidence synthesis 25.1: Effectiveness of trivalent and quadrivalent influenza vaccines in preventing infection, hospitalization, and severe outcomes in the 2023–2024 season onwards

dc.contributor.author	Wu, N
dc.contributor.author	Bain, T
dc.contributor.author	Bhuiya, AR
dc.contributor.author	Phelps, A
dc.contributor.author	Dass, R
dc.contributor.author	Sivanesanathan, T
dc.contributor.author	Wilson, MG
dc.date.accessioned	2025-09-24T18:00:13Z
dc.date.available	2025-09-24T18:00:13Z
dc.date.issued	2024-11
dc.description.abstract	An in-depth synthesis of what is known, based on the best available research evidence from around the world (i.e., evidence syntheses) and local research evidence (i.e., single studies), about the effectiveness of trivalent and quadrivalent influenza vaccines in preventing infection, hospitalization, and severe outcomes in the 2023–2024 season onwards.	en_US
dc.description.sponsorship	This living evidence synthesis was commissioned and funded by the Office of the Chief Science Officer, Public Health Agency of Canada.	en_US
dc.identifier.citation	Wu N, Bain T, Bhuiya A, Phelps A, Dass R, Sivanesanathan T, Wilson MG. Living evidence synthesis 25.1. Effectiveness of trivalent and quadrivalent influenza vaccines in preventing infection, hospitalization, and severe outcomes in the 2023–2024 season onwards. Hamilton: McMaster Health Forum, 7 November 2024.	en_US
dc.identifier.uri	http://hdl.handle.net/11375/32390
dc.language.iso	en	en_US
dc.relation.ispartofseries	LES 25.1;
dc.subject	trivalent	en_US
dc.subject	quadrivalent	en_US
dc.subject	influenza	en_US
dc.subject	vaccines	en_US
dc.subject	infection	en_US
dc.subject	hospitalization	en_US
dc.title	Living evidence synthesis 25.1: Effectiveness of trivalent and quadrivalent influenza vaccines in preventing infection, hospitalization, and severe outcomes in the 2023–2024 season onwards	en_US

Files

Original bundle

Now showing 1 - 2 of 2

Name:: Living Evidence Synthesis 25.1 - Effectiveness of trivalent and quadrivalent influenza vaccines in preventing infection, hospitalization, and severe outcomes in the 2023-2024 season onwards.pdf
Size:: 397.21 KB
Format:: Adobe Portable Document Format

Download

Name:: Living Evidence Synthesis 25.1 - Appendices.pdf
Size:: 510.52 KB
Format:: Adobe Portable Document Format

Download

License bundle

Now showing 1 - 1 of 1

Name:: license.txt
Size:: 1.68 KB
Format:: Item-specific license agreed upon to submission
Description:

Download

Collections

Living evidence synthesis